Literature DB >> 16546352

Genetic variations in ZFP36 and their possible relationship to autoimmune diseases.

Danielle Mercatante Carrick1, Patricia Chulada, Rachelle Donn, Martina Fabris, Janet McNicholl, William Whitworth, Perry J Blackshear.   

Abstract

The ZFP36 gene codes for TTP, a regulator of TNF alpha. In mice, TTP deficiency results in a systemic autoimmune inflammatory syndrome with severe arthritis. We hypothesized that genetic variations in ZFP36 are associated with autoimmune disease in humans. The primary objective of this study was to identify human ZFP36 genetic variants in autoimmune disease cases and controls, determine their frequencies in a general clinic population, and construct haplotypes. We resequenced ZFP36 in 316 individuals with autoimmune diseases and identified 28 polymorphisms and determined the frequency of all the known ZFP36 polymorphisms in 484 participants of the Environmental Polymorphism Registry, a regional registry being conducted by the NIEHS. Based on the sequence-verified ZFP36 genotypes, 34 haplotypes were constructed. As a secondary objective, we examined autoimmune disease cases and controls for potential ZFP36 genetic associations. One novel polymorphism, ZFP36*8, a C to T transition in the protein coding domain, was significantly associated with rheumatoid arthritis (RA) in African-Americans (RR=1.23, 95% CI: 1.11-1.36). The data presented here suggest a tentative association between ZFP36 and RA. This finding, as well as the ZFP36 polymorphisms and haplotypes identified here, should form the basis for future association studies in autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546352     DOI: 10.1016/j.jaut.2006.01.004

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  19 in total

Review 1.  The roles of TTP and BRF proteins in regulated mRNA decay.

Authors:  Sandhya Sanduja; Fernando F Blanco; Dan A Dixon
Journal:  Wiley Interdiscip Rev RNA       Date:  2011 Jan-Feb       Impact factor: 9.957

2.  MicroRNA targets in immune genes and the Dicer/Argonaute and ARE machinery components.

Authors:  Ananthi J Asirvatham; Christopher J Gregorie; Zihua Hu; William J Magner; Thomas B Tomasi
Journal:  Mol Immunol       Date:  2007-12-03       Impact factor: 4.407

3.  Perspectives on the ARE as it turns 25 years old.

Authors:  Daniel Beisang; Paul R Bohjanen
Journal:  Wiley Interdiscip Rev RNA       Date:  2012-06-25       Impact factor: 9.957

4.  Association of BTG2, CYR61, ZFP36, and SCD gene polymorphisms with Graves' disease and ophthalmopathy.

Authors:  Tereza Planck; Bushra Shahida; Marketa Sjögren; Leif Groop; Bengt Hallengren; Mikael Lantz
Journal:  Thyroid       Date:  2014-06-03       Impact factor: 6.568

Review 5.  RNA-binding proteins in immune regulation: a focus on CCCH zinc finger proteins.

Authors:  Mingui Fu; Perry J Blackshear
Journal:  Nat Rev Immunol       Date:  2016-12-19       Impact factor: 53.106

Review 6.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

7.  Genetic polymorphisms in RNA binding proteins contribute to breast cancer survival.

Authors:  Rohit Upadhyay; Sandhya Sanduja; Vimala Kaza; Dan A Dixon
Journal:  Int J Cancer       Date:  2012-09-18       Impact factor: 7.396

8.  Comparison of three anti-CCP antibody tests and rheumatoid factor in RA and control patients.

Authors:  Ma Lurdes Correia; Saudade Carvalho; Jorge Fortuna; Ma Henriqueta Pereira
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

9.  Tristetraprolin impairs NF-kappaB/p65 nuclear translocation.

Authors:  Yvonne M Schichl; Ulrike Resch; Renate Hofer-Warbinek; Rainer de Martin
Journal:  J Biol Chem       Date:  2009-08-04       Impact factor: 5.157

Review 10.  TIS11 family proteins and their roles in posttranscriptional gene regulation.

Authors:  Maria Baou; Andrew Jewell; John J Murphy
Journal:  J Biomed Biotechnol       Date:  2009-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.